EcoDrugPlus

Ensembl ID : tetur03g05190
Gene Symbol: -
External references: -
150 Possible Orthologues:

Ensembl ID : tetur03g05250
Gene Symbol: -
External references: -
82 Possible Orthologues:

Ensembl ID : tetur03g06070
Gene Symbol: -
External references: -
315 Possible Orthologues:

Ensembl ID : tetur03g06180
Gene Symbol: -
External references: -
58 Possible Orthologues:

Ensembl ID : tetur03g06850
Gene Symbol: -
External references: -
33 Possible Orthologues:

Ensembl ID : tetur03g07360
Gene Symbol: -
External references: -
68 Possible Orthologues:

Ensembl ID : tetur03g07740
Gene Symbol: -
External references: -
74 Possible Orthologues:

Ensembl ID : tetur03g08360
Gene Symbol: -
External references: -
97 Possible Orthologues:

Ensembl ID : tetur03g08620
Gene Symbol: -
External references: -
95 Possible Orthologues:

Ensembl ID : tetur03g09997
Gene Symbol: -
External references: -
120 Possible Orthologues:

Ensembl ID : tetur04g01930
Gene Symbol: -
External references: -
412 Possible Orthologues:

Ensembl ID : tetur04g02220
Gene Symbol: -
External references: -
76 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).